Buradasınız

Anasayfa » Content

Lösemi ve Lenfomaların İrdelenmesi ve Teşhisinde Flow Sitometrik İmmün Tip Tayini

Flow cytometric immunophenotyping in the evaluation and diagnosis of leukemias and lymphomas

Journal Name:

  • İnönü Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 1996

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Surface membran antigen analysis (immunophenotyping) and DNA content analysis are the two most common applications offlow cytometry in oncology field. Surface membrane antigen analysis is used in the diagnosis and classification of leukemias and lymphomas. Flow cytometric immunophenotyping is helpful for monitoring of patients and also has prognostic value. The technology of flow cytometry and monoclonal antibody have added new dimensions in the evaluation of leukemias and lymphomas. In this study immunophenotypic features of hematologic malignancies are reviewed. [Journal of Turgut Özal Medical Center 1996;3(2):130-136]
Bookmark/Search this post with
Abstract (Original Language): 
Yüzey membran antijen analizi (immünofenotipleme) ve DNA içerik analizi onkoloji alanında en yaygın iki uygulama offlow sitometri vardır. Yüzey membran antijen analizi lösemi ve lenfomaların tanı ve sınıflandırılmasında kullanılır. Akış sitometrik immünofenotipleme hastaların izlenmesi için yararlı ve aynı zamanda prognostik değeri vardır. Flow sitometri ve monoklonal antikor teknolojisi lösemiler ve lenfomalar değerlendirilmesinde yeni boyutlar ekledi. Bu çalışmada hematolojik maligniteler immünfenotipik özellikleri gözden geçirilmiştir. [Turgut Özal Tıp Merkezi 1996 Dergisi, 3 (2) :130-136]
FULL TEXT (PDF): 
PDF icon arastirmax-losemi-lenfomalarin-irdelenmesi-teshisinde-flow-sitometrik-immun-tip-tayini.pdf
  • 2
130-136
  • Turkish

REFERENCES

References: 

1. Shapiro HM. Practical Flow cytometry; 2nd ed. Alan R. Liss, Inc. New York: 1988.
2. Huh OY, Huck L. Oncology application of flow cytometry.Clin lab Sci l992;5:25-7.
3. Coon JS, Landay AL, Weintein RS. Biology of disease: Advances in flow cytometry for diagnostic pathology. Laboratory Investigation 1987;57:473-9.
4. Nicholson JKA. Use of flow cytometry in the evaluation and diognosis of primary and secondary immunodeficiency diseases. Arch Pathol Lab Med l989;113:598-605.
5. Huang S,Terstappen LWMM. Formation of haematopoietic microenvironment and haematopoietic stem cells from single human bone marrow stem cells. Nature 1992;360:745-9.
6. Cotran Rs, Kumar V,Robbins SL: Robbins pathologic basis of disease. 4th.ed. W.B.Saunders Company 1989.
7. Deegan MJ. Membrane antijen analysis in the diagnosis of lymphoid leukemias and lymphomas. Arch Pathol Lab Med 1989; 113:606-18.
8. Dugue RE, Everett ET, Hurraspe J. Flow Ctometric analysis of acute leukemias. Clinical Immunology Newsletter
1990:10:43-62.
9. Andreef M. Flow cytometry of leukemia. In: Melamed MR. editor. Flow Cytometry and Sorting. 2nd ed. New York Wiley.
Liss, Inc. 1990: 697-724.
10. Chandrasoma P, Taylor CR. Concise Pathology. 1st ed.
Prentice-Hall Int. Inc.1991.
11. Ryan DH, Fallon MA, Horan PK. Flow cytometry in the
clinical laboratory. Clinica Chimica Acta 1988;171: l25-74.
12. Carey JL. Flow cytometric immunophenotyping of leukemias and lymphomas. ASCP 1992 teleconference series.
13. Lovett EJ, Schnitzer B, Keren DF, Flint A, Hudson J, McClathey KD. Application of flow cytometry to diagnostic pathology. Laboratory Investigation l984 ; 50:115-39.
14. Traweek ST. Immunophenotypic analysis of acute leukemia.
Am J Clin Pathol 1993;4: 504-12.
15. Huh OY. Surface markers in acute and chronic leukemia and nonHodgkin's lymphoma. The Cancer Bulletin 1993; 45:78¬85.
16. Lerner NB, Nocka KH, Cole SR, Qiu F, Strife A, Ashman LK, Besmer P. Monoclonal antibody YB5.B8 identifies the human c-kit protein product. Blood 1991;77:1876-83.
17. Bütring HJ, Villrich A, Schaudt K,Müller CA, Busch FW. The product of the proto-oncogene c-kit(P145 c kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells. Leukemia 1991;5:854-60.
18. Griffin JD, Davis R, Nelson DA, Davey FR,Mayer RJ, Schiffer C, McIntyre R, Bloomfield CD. Use of surface marker analylsis to predict outcome of adult acute myeloblastic leukemia. Blood l986; 68: 1232-41.
19. Lombard EH, Manswelt EPG. CD4+, CD33-,CD13-,CD14-acute monoblastic leukemia. Acta Haematol 1992;87:151-2.
20. Kondo S, Okamura S, Harada N, Ikematsu W, Kawasaki C, Fukuda T, et al. CD7 positive acute myeloid leukemia: Further evidence of cellular immaturity. J Cancer Res Clin
Oncol 1992; 118: 386-88.
21. Drexler HG, Thiel E, Ludwig WF. Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance. Leukemia 1993;7:489-98.
22. Kantarjian HM, Ginsberg CH, Yee G, Huh Y, Freireich EJ,
Stass S. Mixed lineage leukemia revisited: acute lymphoblastic leukemia with myeloperoxidase-positive blasts by electron
microscopy. Blood 1990;76: 808-13.
23. Drach D, Drach J, Glassl H, Gattringer C, Huber H. Flow
cytometric dedection of cytoplasmic antigens in acute leukemias: implications for lineage assignment. Leukemia Research 1993;17: 455-61.
24. Ginsberg CH, Kagan J, Liang JC, stass SA. Recent advances in the diagnosis of acute leukemia. The Cancer Bulletin
1993;45:64-77.
25. Fovcar K, Chen IM, Crago S. Organization and operation of a flow cytometric immunophenotyping laboratory. Seminars in Diagnostic Pathology 1989;6: 13-36.
26. Braylan RC, Benson NA. Flow cytometric analysis of
lymphomas. Arch Pathol Lab Med 1989;113;627-33.
27. Bray RA, Landay AL. Identification and functional characterization of mononuclear cells by flow cytometry. Arch
Pathol Lab Med 1989;113:579-90.
28. Miller Ml, Fischleder AJ, Tubbs RR. The expression of CD22
(leu14) and CD11c (leuM5) in chronic lymphoproliferative disorders using two-color flow cytometric analysis . Am J Clin
Pathol 1991; 96: 100-8.
29. Batata A, Shen B. Chronic lymphocytic leukemia with low
lymphocyte count. Cancer 1993;71:2732-8.
30. Dighiero G. An attempt to explain disordered immunity and hypogammaglobulinemia in B-CLL. Nouv Rev Fr Hematol
1988; 30:283-8.
31.
Aydý
n A. B tipi kronik lenfositik lösemide Ki-67 monoklonal antikoru, hücre RNA içeriði, S+G2M fraksiyonunun flow sitometri ile ölçümleri ve interlökin-2 reseptör (CD25) pozitifliðiyle korelasyonlarý. Uzmanlýk Tezi Ýzmir 1993.
32. Harris NL. The pathology of lymphoma. Surg Oncol Clin North Am 1993;2:167-206.
33. Weisenburger DD, Chan WC. Lymphomas of follicles; mantle cell and follicle center cell lymphomas. Am J Clin Pathol
1993;99:409-20.
34. Little JV, Foucar K. Horvath A, Crago S. Flow cytometric analysis of lymphoma and lymphoma-like disorders. Sem
Diagn Pathol 1989;6:37-54.
35. Andreef M. Flow cytometry of lymphoma. In: Melamed MR ed. Flow cytometry and Sorting. 2nd ed. New York Wiley-
Liss, Inc. 1990:725-43.
36. Barcos M. Mycosis fungoides; diagnosis and pathogenesis Am
J Clin Pathol 1993;99:452-8.

Thank you for copying data from http://www.arastirmax.com